Abstract. Sex steroid concentrations in urine samples from post-menopausal women have been associated with risk of various chronic diseases. The basic requirement for the assessment of risk in such largescale epidemiological studies is that subjects be ranked accurately by their average, long-term hormone levels. We examined the reproducibility over time of measurements of urinary testosterone (T), 5a-androstane-3a, 17b-diol (ADIOL), estrone (E 1 ), estradiol (E 2 ), 2-hydroxy estrone and 2-hydroxy estradiol, (2(OH)-E), 16a-hydroxyestrone (16a(OH)-E 1 ) and the ratio of 2(OH)-E and 16a(OH)-E 1 , in a representative sub-sample of post-menopausal women (n ¼ 43) participating in an ongoing prospective cohort study. Women collected three first morning urine voids on different occasions, with average time difference between the first and the third urine sample of 5.1 years. T, ADIOL, E 1 and E 2 were measured by radio immunoassay after enzymatic hydrolysis, solidphase extraction and HPLC purification of the samples, while 2(OH)-E and 16a(OH)-E 1 were assayed by solid-phase enzyme immunoassay after enzymatic hydrolysis. Intra-class correlation co-efficients (ICCs) over time were very good for T (r ¼ 0.85), acceptable for E 2 , E 1 and ADIOL (r > 0.55), but low for 2(OH)-E, 16a(OH)-E 1 and their ratio (r < 0.46). The adjustment for creatinine concentrations did not increase these correlations.
Introduction
Sex steroid concentrations in blood or urine of postmenopausal women have been associated with an increase in risk of various chronic diseases, including cancer [1, 2] and osteoporosis [3, 4] . Although blood samples have been used in many studies, urine samples may be collected in large-scale epidemiological studies for a number of reasons. First, contrary to blood withdrawal, urine collection is non-invasive and can be done directly by the study subjects, without medical assistance. Second, the collection of overnight or 24-hour urine samples may minimise variability of hormones that show a pulsatile secretion or diurnal variability (e.g., cortisol, growth hormone) [5, 6] . Finally, certain hormones can only be measured accurately in urine, because plasma levels are very low (e.g., 2/16a-hydroxy estrogen metabolites) [7, 8] .
A difficulty inherent in epidemiological studies of hormones is that random errors in the measurement of individuals' hormone levels attenuate relative risk estimates and decrease the power of statistical tests for hormone-disease association [9] . The basic requirement for the accurate assessment of relative risk in epidemiological studies is that subjects be ranked accurately by their average, long-term hormone levels. While several studies have been published on the reproducibility and validity of hormone measurements in blood over time [10] [11] [12] [13] , few have addressed the reproducibility and validity of these measurements in urine samples [14, 15] .
In preparation for a prospective study on breast cancer risk and sex-steroid concentrations in first morning voids from post-menopausal women in a Dutch prospective cohort, we examined the reproducibility over time of measurements of urinary testosterone (T), 5a-androstane-3a, 17b-diol (ADIOL), estrone (E 1 ), estradiol (E 2 ), 2-hydroxy estrone and 2-hydroxy estradiol (2(OH)-E), 16a-hydroxyestrone (16a(OH)-E 1 ) and the ratio between 2(OH)-E and 16a(OH)-E 1 .
Material and methods

Subjects and urine collections
All women born between 1911 and 1945 living in Utrecht and surroundings were invited to participate in a large population based screening programme for early detection of breast cancer (the DOM-cohort) between 1975 and 1986 [16] . Women who responded to the first invitation to participate in this study were then invited for regular screening examinations. At each visit the women filled in a lifestyle questionnaire containing questions regarding breast cancer risk factors, medical history, exogenous hormone use and last day of the cycle. Furthermore, anthropometric measurements (height, weight, waist and hip circumferences) were taken for all participants, and the women were asked to bring a first morning urine sample on the day of their examination. Upon their arrival at the laboratory, urine samples were stored at )20°C in 250-ml plastic polypropylene jars with a screw cap, without preserving agents.
Forty-three women were randomly selected from the 27,718 women participating in the DOM-cohort. The women were post-menopausal at recruitment (natural menopause defined as no menstruation during the previous 12 months and no surgical interventions), did not use exogenous hormones, and had provided at least three different urine samples.
The average time difference between the collection of the first (t1) and the second (t2) urine sample was 1.1 year (minimum 0.9 years, maximum 4.4 years), while it was 4.0 years between the second and the third (t3) sample (minimum 1.3 years, maximum 7.7 years). Urine samples were shipped on dry ice to the Hormone and Cancer Group, International Agency for Research on Cancer (IARC) laboratory for hormone analyses. On their arrival, samples were re-aliquotted in 3 ml-aliquots and stored at )80°C until analysis. One aliquot was then used for the simultaneous measurements of T, ADIOL, E 1 and E 2 , and a second one for the measurement of 2(OH)-E and 16a(OH)-E 1 .
Sex-steroid assays T, ADIOL, E 1 and E 2 T, ADIOL, E 1 and E 2 were measured by radioimmunoassay (RIA) after enzymatic hydrolysis, solid phase extraction and high-performance liquid chromatography (HPLC) purification of the urinary samples.
The method for hydrolysis and purification of urinary sex-steroids has been described previously in detail [17, 18] . In brief, 1 ml of acetate buffer (pH ¼ 5.2) and 5.6 mg of Helix Pomatia powder (Sigma-Aldrich Chimie, Lyon, France) were added to a 2-ml sample of urine, and the samples were incubated at 45°C for 22 hour. After hydrolysis, the samples were extracted by a C18 cartridge (LiChrolut, 500 mg) coupled to a NH 2 cartridge (LiChrolut, 200 mg, Merck, Darmstadt, Germany). Sex-steroids were eluted with 5 ml of acetonitrile through the column assembly. The eluent was then dried at 37°C, under a gentle stream of dry nitrogen. The dried extract was then redissolved into 400 ll of 50% ethanol solution, passed through a syringe filter and then injected into an HPLC (100 ll) ( 3 H]-labelled tracers of T, E 2 and E 1 were purchased from Amersham Biosciences Europe (Orsay, France), while for ADIOL they were purchased from PerkinElmer (Courtaboeuf, France). Since E 1 and T were eluted in the same fractions, cross-reactivities of the respective antibodies were tested, but were found to be negligible (0.022% for anti-E 1 vs. T, and of 0.0055% for anti-T vs. E 1 ).
All measurements were done in duplicate, including hydrolysis, solid phase extraction, HPLC and RIA steps, and all samples collected from each subject were measured randomly in the same HPLC and RIA analytical batch. Laboratory technicians were blind to the time of sampling of the samples (t1, t2, or t3). For quality control, two control samples containing known amount of steroids were run through all the analysis (from hydrolysis to RIA) in each analytical batch. Intra-batch coefficients of variation were 6.9% for E 1 (at a concentration of 1900 ng/l), 4.7% for E 2 (at a concentration of 530 ng/l), 9.3% for ADIOL (at a concentration of 14,500 ng/l) and 6.7% for T (at a concentration of 2900 ng/l). Interbatch coefficients of variation were 16% for E 1 , 17% for E 2 , 15% for ADIOL and 10% for T at the same concentrations. The detection limits of the method were 2.0 ng/100 ml for E 1 and E 2 , 7.8 ng/100 ml for ADIOL and 1.6 ng/100 ml for T.
Results were expressed as concentrations, in ng analyte per litre. To correct for the variability in urine dilution, creatinine was measured in each sample by kinetic Jaffe´reaction (Hitachi 717, Roche, Central Laboratory for Biochemistry, Hoˆpital de l'Antiquaille, Lyon, France), and results were also expressed per mg creatinine.
Recovery and surcharge tests for hormone concentrations within the post-menopausal range were performed in duplicate for each hormone on three different urine samples. The dilution tests were done by diluting samples in cascade with urine from which all sex steroids had first been removed by stripping by solid phase extraction. For the surcharge recovery tests, a fixed volume of stripped urine was loaded with increasing, known quantities of each of the four sex steroids. Mean recovery for surcharge tests were 101% for E 1 , 108% for E 2 , 100% for ADIOL and 104% for T. Mean recovery for dilution tests were 94% for E 1 , 104% for E 2 , 119% for ADIOL and 109% for T.
2(OH)-E and 16a(OH)-E 1
2(OH)-E and 16a(OH)-E 1 were measured by solidphase enzyme immunoassay (Estramet, Immuna Care Corporation, Bethlehem, USA), and the analyses were performed according to the protocols from the manufacturer. In brief, each urine sample was hydrolysed by b-glucuronidase/aryl sulfatase in acidic milieu, and was pipetted into microtiter plates with high-affinity murine monoclonal antibody. The enzyme alkaline phosphatase was linked to each estrogen metabolite, which was used for the competition with the standard or the analyte in the assay. Plates were read at end point at 405 nm (paranitrophenyl phosphate as chromogen) by an automated plate reader (Spectracount, Packard, Meriden, USA). All the samples were assayed in triplicate, and samples collected from the same subject were measured in the same analytical batch. The ratio between 2(OH)-E and 16a(OH)-E 1 was calculated from the averages of the triplicate measurements for each sample.
Validity, reproducibility and detection limits of the method have been published previously [19] . In our study, intra-batch coefficients of variation were 10.9% for 2(OH)-E and 12.7% for 16a(OH)-E 1 for concentrations of 3500 ng/l, while inter-batch coefficients of variation were 17.3 and 21.2% for 2(OH)-E and 16a(OH)-E 1 , respectively. For the ratio 2(OH)-E/ 16a(OH)-E 1 , intra-batch coefficients of variation were of 16.3% for a ratio of 1, while inter-batch coefficients of variation were of 17.9%.
All hormone measurements were performed at the laboratory for hormone analyses, Hormones and Cancer Group, IARC (Lyon, France).
Immunoassays were performed using an automated liquid handling system (Multiprobe II, Packard) with computer connections to a liquid scintillation analyser (TRI-CARB 1900CA, Packard) and an UVreader (Spectracount, Packard).
Statistical analyses
Statistical analyses were performed using the SAS statistical software package (SAS Institute Inc., Cary, NC, USA). The natural logarithm was used for all variables, to normalise their frequency distributions. Statistical analyses included the calculation of geometric means and confidence intervals, and calculation of correlation coefficients. Pearson correlations were used to examine the correlations over time of T, ADIOL, E 1 , E 2 , 2(OH)-E, 16a(OH)-E 1 and the ratio 2(OH)-E/16a(OH)-E 1 , and were calculated by computing average values from the three different points in time (t1, t2 and t3) for each hormone and for each subject. Within-and between-subject variations were evaluated by computing intra-class correlation coefficients (ICCs), from the following model:
where y denotes the value obtained by the urinary measurements of the hormones, and the terms on the right hand side are random effects. This corresponds to the variance decomposition: to the between-subjects variation, to within-subject variation, the variation between the three different points in time, and to random errors between the replicates within the same subject and the same sample (laboratory error), respectively. These variances were estimated by maximising the likelihood of the random effect model of Equation (1), as represented by the SAS procedure mixed. The within and between-sample ICCs were calculated as ðVar½between-subject þ Var½within-subjectÞ= ðVar½between-subject þ Var½within-subject þ Var½errorÞ and Var½between-subject=ðVar½between-subject þ Var½within-subject þ Var½errorÞ;
respectively. For creatinine analyses, between-subject variations were evaluated by computing ICCs, from the following model:
This corresponds to the variance decomposition: Calculations of hormone concentrations corrected by creatinine were obtained by the ratio of hormone concentration (expressed in ng/l) and of creatinine concentrations (mg/l). The statistical significance of mean changes in the hormone levels over time was assessed by analysis of variance (ANOVA) (using log-transformed variables). As the numbers of observations within the various blocks were not equal, all analyses of variance were done by generalised linear models, using the SAS statistical software package.
All statistical tests and corresponding p values were two-sided with 95% confidence intervals.
Results
Geometric means and confidence intervals for age, body mass index (BMI), T, ADIOL, E 1 , E 2 , 2(OH)-E, 16a(OH)-E 1 , 2(OH)-E/16a(OH)-E 1 ratios and creatinine are presented in Table 1 . BMI did not change significantly over time. Measurements for all hormones were well above the detection limit of the assay method, and absolute levels were found to be in the range of those previously reported [2, 13, 19, 20] . A trend towards decreased levels from t1 to t3 was observed for all hormones, and for E 1 and E 2 these trends were statistically significant (p < 0.05). The ratio of 2(OH)-E/16a(OH)-E 1 did not show any significant variation over time. The correction for creatinine values reduced the trend towards lower levels over time, although the trends remained substantial for E 1 and E 2 only (p < 0.05). Very similar results were obtained by adjusting hormone levels for creatinine concentrations by multivariate regression analysis (data not shown).
Within-subject variance, error (laboratory replicate) variance, and intra-class (ICCs) and Pearson's correlations over time are shown in Table 2 . ICCs for laboratory replicates were all above 0.93, indicating good analytical reproducibility. Within-subject ICCs ranged from 0.55 to 0.85 for T, ADIOL, E 1 and E 2 , but they were much lower for 2(OH)-E, 16a(OH)-E 1 and their ratio (ICCs < 0.46). The adjustment of results for creatinine levels did not substantially change the ICCs for T, ADIOL, E 1 and E 2 , but slightly increased the ICCs for 2(OH)-E from 0.20 to 0.32, and decreased the ICCs observed for 16a(OH)- The cross-classification of subjects by tertiles of hormone levels over time is presented in Table 3 . To evaluate the accuracy of subject classification by hormone levels on the basis of only one biological sample collection, subjects were classified into tertiles (due to the small sample size). The values on the diagonal line represent the concordance between the ranking of subjects according to the sample collected in t1, and the ranking of subjects according to the mean of samples collected in t2 and t3 (longer exposure over time). For T (within-subject ICCs of 0.85), 81% of the subjects (34 on 42) were well classified (assuming the mean levels of t2 and t3 as reference concentration). For the ratio of 2(OH)-E/ 16a(OH)-E 1 (ICCs = 0.18), only 42% of the subjects (14 on 33) were correctly classified.
Discussion
We evaluated the reproducibility of urinary sex-steroid concentrations over time in first-morning voids from post-menopausal women, measuring T, ADI-OL, E 1 and E 2 by RIA after enzymatic hydrolysis, solid-phase extraction and HPLC purification of the Tertile for mean of sample 2 and 3  1  2  3  Tertile for sample 1  1  5  3  2  10  2  2  4  4  1 0  3  4  4  5  1 3  11  11  11 Values on the diagonal line represent concordance between sample in t1 and the mean of samples in t2 and t3. a Nine women were missing one value of either 2(OH)-E or 16a(OH)-E 1 and were therefore excluded from the analyses.
samples, and 2(OH)-E and 16a(OH)-E 1 by solidphase enzyme immunoassay. Reproducibility over time was found to be good for T, reasonably high for ADIOL, E 1 and E 2 , but low for 2(OH)-E, 16a(OH)-E 1 and the ratio of 2(OH)-E/16a(OH)-E 1 . For all hormones, there was a trend toward lower concentrations with time, possibly reflecting decreased production with age [21] . In fact, the lowest concentrations of hormones were found at t3 (between 2.2 and 8.8 years after t1), the time point at which women were the oldest, and further in time from the start of menopausal status. The decrease in hormone levels was higher for E 1 and E 2 than for the other hormones, while the ratio between 2(OH)-E and 16a(OH)-E 1 remained constant over time. The decrease in estrogens was far greater than the decrease in creatinine, and persisted after adjustment for creatinine. This suggests that this hormone decrease was not due to changes in urine volumes.
The trend toward lower concentrations over time (before and after the adjustment for creatinine values, for almost all hormones) suggested that there were probably no major problems of sex steroid degradation with storage, since the samples that were stored the longest had the highest concentrations. This confirms previous observations for T, E 1 and E 2 [22, 23] . Our study also showed that 2(OH)-E and 16a(OH)-E 1 were stable enough to be measured in urine samples stored at )20°C for more 25 years without any added preserving agents. Absolute values in the frozen samples were not different from those in fresh urine samples from post-menopausal women (average data within ''normal'' post-menopausal range on fresh urine samples were provided by the kit manufacturer), or in urine samples that were stored for much shorter periods of time, measured with the same method [8, [24] [25] [26] . The apparent stability of hormones during storage time, even at a temperature of )20°C, may be an important issue for prospective epidemiological studies in which biological samples are stored frozen over many years.
To our knowledge, only one study has been published so far on the reproducibility of urinary sex steroid measurements over time in post-menopausal women [15] . In this previous study, 60 women who participated as controls in a case-control study were invited to give a second 24-hour urine sample approximately 1 year after the first sample. For postmenopausal women, Pearson's correlation coefficients were found to be 0.41 for T and 0.57 for ADIOL. In our study we found within-subject ICCs of 0.85 for T and 0.55 for ADIOL for measurements over time, despite the fact that our measurements were performed on first-morning voids, rather than on 24-hour urine samples, and despite the longer time intervals between samples. Two other studies have reported the reproducibility of urinary hormones over time, but they focused only on estrogen metabolites in pre-menopausal women [14, 27] . Over a 1-year interval, ICCs in the luteal phase were found to range from 0.56 for 16(OH)-E 1 to 0.71 for the ratio between the two metabolites [14] , and over a 2-month interval, correlations were found to be even higher [27] . In our study, ICCs over-time for estrogen metabolites in post-menopausal women were not satisfactory. This could have different explanations. First, measurements of estrogens metabolites in urine samples from post-menopausal women could be problematic, since absolute levels are lower compared to levels found in pre-menopausal women [19, 26] . Second, the time interval between the urine samples in our study was longer than in the previous studies (between 0.9 and 7.7 years). Third, the ratio between 2(OH)-E and 16a(OH)-E 1 could be influenced by changes in diet [28, 29] and smoking habit [30] , factors that could easily vary over a long period of time. Furthermore, the width of the confidence intervals of ICCs and Pearson's correlation coefficients for 2(OH)-E, 16a(OH)-E 1 and their ratio could suggest that the power of the study is rather limited for those hormones.
Urine collection over 24-hours is known to be the best option to accurately determine a woman's daily hormone excretion [31] , but in practice this kind of collection represents a heavy burden for study participants. First-morning voids or overnight collections can be obtained more easily, but may decrease somewhat the reliability of measurements. Most of the studies published on hormone measurements in overnight urine samples or first morning voids use creatinine measurements to adjust for dilution errors [32, 33] . Some papers have questioned whether such creatinine adjustments will actually reduce, or rather increase, measurement errors [34] [35] [36] . Creatinine excretion can vary depending on muscle mass, physical exercise, diet and age [35, 37] of the subjects. In addition, creatinine measurements are subjected to methodological errors as are any other measurements. In our study, the adjustment for creatinine did not substantially change the ICCs of hormones over time. Creatinine ICC over time was only 0.46. Since creatinine is an index of lean body mass [38] , this low ICC could be due to variation in the loss of lean body tissue during aging.
In conclusion, the classification of T, ADIOL, E 1 and E 2 concentrations in first morning urine samples from post-menopausal women appeared to be quite reproducible over time. Reproducibility of 2(OH)-E and 16a(OH)-E 1 and the ratio of 2(OH)-E/16a(OH)-E 1 , on the other hand, appeared to be very low over a long period of time. Thus, urinary measurements of sex-steroids by RIA after sample purification appears to be an appropriate alternative to serum measurements in epidemiological studies, as a non-invasive method easy-to-apply on a large scale. The high variability of 2(OH)-E and 16a(OH)-E 1 , however, suggests that one urine sample may not be representative of these metabolites over time.
